Close Menu

Lung Cancer

News and reporting on lung cancer.

The funding will be used by Insight to develop companion diagnostics for lung cancer.

A number of prominent proteomics-based diagnostics developers were recipients of the grant and tax credit awards, which are being provided by the IRS through the Patient Protection and Affordable Care Act's Qualifying Therapeutic Discovery Project Program.

The trial plans to study whether it is cost-effective to use a genetic test and CT scans to identify smokers at risk of getting lung cancer.

The merger will give Biosystems International access to MicroBioChips' nanoarray technology and its sales and marketing resources, which are expected to help the company establish new relationships with university-based proteomics laboratories and pharma and biotech firms.

The agreement with NEC, which has purchased an equity stake in the company, is part of its plan to expand beyond its traditional focus on biomarker discovery and diagnostics development to become a "health information company" that can "provide actionable medical information to patients, physicians, and researchers," said an official.

The donation will fund research at the Institute for Personalized Cancer Therapy and the Center for Targeted Therapy into more effective drug treatments, including investigations into protein pathway-directed therapies, said an official.

Results from the 94-subject study suggest that the test could be useful in screening high-risk patients for ovarian cancer and possibly even as a screening diagnostic for the general population, a Georgia Tech researcher said.

In a study, Merck scientists identified 71 phosphoproteins that could be useful biomarkers for predicting the efficacy of drugs targeting a cancer-linked signaling pathway.

The company next year plans to launch a 1,000-patient verification trial for its lung cancer protein biomarker panel, with trials for its Alzheimer's disease panel likely to follow, said an official.

The center will focus on developing biomarker panels for measuring patient response to drug treatments for lung cancer, chronic obstructive pulmonary disease, and cardiovascular disease, said one of its founders.

Pages

Following discrimination allegations, NICHD's Constantine Stratakis withdraws from a new position at the Research Institute of the McGill University Health Center, Science reports.

US President Donald Trump has threatened to cut World Health Organization funding over its pandemic response, which would affect its ability to do its work and which he might not be able to do.

The US Securities and Exchange Commission has halted the sales of a handful of stocks over claims made about the coronavirus.

In Nature this week: comparative analyses of single-cell RNA sequencing protocols uncover differences between approaches, and more.